Results 11 to 20 of about 3,308 (205)

Testing the Novel Weapons Hypothesis of the Argentine Ant Venom on Amphibians. [PDF]

open access: yesToxins (Basel), 2023
The globally invasive Argentine ant (Linepithema humile) possesses a venom lethal to some amphibian species in the invaded range. To test the novel weapons hypothesis (NWH), the effects of the toxin on the cohabiting amphibian species in the ant’s ...
Llopart JP   +5 more
europepmc   +8 more sources

Fire Ant Venom Alkaloids: Possible Control Measure for Soilborne and Foliar Plant Pathogens. [PDF]

open access: yesPathogens, 2021
The purpose of this study was to evaluate fire ant venom alkaloids and an alarm pheromone analog against several plant pathogens, including Botrytis cinerea, Fusarium oxysporum, Phytophthora nicotianae, P.
Dawadi S   +4 more
europepmc   +5 more sources

Discovery of an Insect Neuroactive Helix Ring Peptide from Ant Venom. [PDF]

open access: yesToxins (Basel), 2023
International audienceAnts are among the most abundant terrestrial invertebrate predators on Earth. To overwhelm their prey, they employ several remarkable behavioral, physiological, and biochemical innovations, including an effective paralytic venom ...
Barassé V   +19 more
europepmc   +3 more sources

Combined Venom Gland Transcriptomic and Venom Peptidomic Analysis of the Predatory Ant Odontomachus monticola

open access: yesToxins, 2017
Ants (hymenoptera: Formicidae) have adapted to many different environments and have become some of the most prolific and successful insects. To date, 13,258 ant species have been reported.
Kohei Kazuma   +3 more
core   +3 more sources

Biological Activities and Ecological Significance of Fire Ant Venom Alkaloids. [PDF]

open access: yesToxins (Basel), 2023
Venoms produced by arthropods act as chemical weapons to paralyze prey or deter competitors. The utilization of venom is an essential feature in the biology and ecology of venomous arthropods.
Xu G, Chen L.
europepmc   +3 more sources

Transcriptome analysis in venom gland of the predatory giant ant Dinoponera quadriceps: insights into the polypeptide toxin arsenal of hymenopterans. [PDF]

open access: yesPLoS ONE, 2014
BACKGROUND: Dinoponera quadriceps is a predatory giant ant that inhabits the Neotropical region and subdues its prey (insects) with stings that deliver a toxic cocktail of molecules.
Alba F C Torres   +19 more
core   +2 more sources

Ant venom immunotherapy in Australia: the unmet need [PDF]

open access: yesMedical Journal of Australia, 2014
Jack jumper ant (JJA) venom allergy is an important cause of anaphylaxis in south-eastern Australia. The efficacy and real-world effectiveness of JJA venom immunotherapy (VIT) to prevent anaphylaxis in allergic patients are now well established, with an evidence base that is at least equivalent to that supporting VIT for allergy to other insect species.
Mullins, Raymond, Brown, Simon GA
openaire   +5 more sources

Bottom-Up Proteomic Analysis of Polypeptide Venom Components of the Giant Ant Dinoponera Quadriceps

open access: yesToxins, 2019
Ant species have specialized venom systems developed to sting and inoculate a biological cocktail of organic compounds, including peptide and polypeptide toxins, for the purpose of predation and defense.
André Junqueira Zaharenko   +5 more
core   +2 more sources

Mass Spectrometry Analysis and Biological Characterization of the Venom and Venom Sac Components of the Predatory Ant Odontomachus monticola

open access: yesToxins, 2019
We previously identified 92 toxin-like peptides and proteins, including pilosulin-like peptides 1–6 from the predatory ant Odontomachus monticola, by transcriptome analysis.
Kohei Kazuma   +6 more
core   +2 more sources

Studying the Rationale of Fire Ant Sting Therapy Usage by the Tribal Natives of Bastar Revealed Ant Venom-Derived Peptides with Promising Anti-Malarial Activity. [PDF]

open access: yesToxins (Basel), 2022
Prevailing drug resistance in malaria imposes the major roadblock for the existing interventions necessitating the timely need to search for alternative therapies.
Kumari J   +5 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy